BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 23837977)

  • 1. [Expression of insulin-like growth factor 2 mRNA-binding protein 3 expression and analysis of prognosis in the patients with lung squamous cell carcinoma].
    Lin L; Zhang J; Wang Y; Zheng L; Lin Z; Cai Y
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Jul; 29(7):694-7. PubMed ID: 23837977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IMP3 Predicts Invasion and Prognosis in Human Lung Adenocarcinoma.
    Yan J; Wei Q; Jian W; Qiu B; Wen J; Liu J; Fu B; Zhou X; Zhao T
    Lung; 2016 Feb; 194(1):137-46. PubMed ID: 26608347
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-like growth factor II-messenger RNA-binding protein-3 and lung cancer.
    Findeis-Hosey JJ; Xu H
    Biotech Histochem; 2012 Jan; 87(1):24-9. PubMed ID: 21838610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Laminin-5 and insulin-like growth factor-II mRNA binding protein-3 (IMP3) expression in preoperative biopsy specimens from oral cancer patients: Their role in neural spread risk and survival stratification.
    Tarsitano A; Asioli S; Morandi L; Monti V; Righi A; Morselli Labate AM; Nardi E; Foschini MP; Marchetti C
    J Craniomaxillofac Surg; 2016 Dec; 44(12):1896-1902. PubMed ID: 27863864
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tumor-specific Expression of Insulin-like Growth Factor II mRNA-binding Protein 3 Independently Predicts Worse Survival of Patients With Adenocarcinoma of the Ampulla of Vater.
    Kim HG; Park MS; Sung JY; Kim YW; Kim HS; Na K
    Anticancer Res; 2019 Sep; 39(9):4947-4955. PubMed ID: 31519600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of insulin-like growth factor II mRNA-binding protein 3 in squamous cell carcinomas of the head and neck.
    Clauditz TS; Wang CJ; Gontarewicz A; Blessmann M; Tennstedt P; Borgmann K; Tribius S; Sauter G; Dalchow C; Knecht R; Münscher A; Wilczak W
    J Oral Pathol Med; 2013 Feb; 42(2):125-32. PubMed ID: 22643116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IMP3 is a novel biomarker to predict metastasis and prognosis of tongue squamous cell carcinoma.
    Li HG; Han JJ; Huang ZQ; Wang L; Chen WL; Shen XM
    J Craniofac Surg; 2011 Nov; 22(6):2022-5. PubMed ID: 22067851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IMP3 is a novel prognostic marker that correlates with colon cancer progression and pathogenesis.
    Li D; Yan D; Tang H; Zhou C; Fan J; Li S; Wang X; Xia J; Huang F; Qiu G; Peng Z
    Ann Surg Oncol; 2009 Dec; 16(12):3499-506. PubMed ID: 19672661
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RNA-binding protein insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor invasion and predicts early recurrence and poor prognosis in hepatocellular carcinoma.
    Jeng YM; Chang CC; Hu FC; Chou HY; Kao HL; Wang TH; Hsu HC
    Hepatology; 2008 Oct; 48(4):1118-27. PubMed ID: 18802962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of RNA-binding protein IMP3 to predict metastasis and prognosis of renal-cell carcinoma: a retrospective study.
    Jiang Z; Chu PG; Woda BA; Rock KL; Liu Q; Hsieh CC; Li C; Chen W; Duan HO; McDougal S; Wu CL
    Lancet Oncol; 2006 Jul; 7(7):556-64. PubMed ID: 16814207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell carcinomas of the ovary: a mono-institutional study of 73 cases in China with an analysis of the prognostic significance of clinicopathological parameters and IMP3 expression.
    Bi R; Shen X; Zhang W; Cheng Y; Feng Z; Cai X; Yang W
    Diagn Pathol; 2016 Feb; 11():17. PubMed ID: 26837693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic value of tissue and circulating levels of IMP3 in prostate cancer.
    Szarvas T; Tschirdewahn S; Niedworok C; Kramer G; Sevcenco S; Reis H; Shariat SF; Rübben H; vom Dorp F
    Int J Cancer; 2014 Oct; 135(7):1596-604. PubMed ID: 24615121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IMP3 is a novel biomarker to predict metastasis and prognosis of gastric adenocarcinoma: a retrospective study.
    Wang L; Li HG; Xia ZS; Lü J; Peng TS
    Chin Med J (Engl); 2010 Dec; 123(24):3554-8. PubMed ID: 22166630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of downregulated ADARB1 in lung squamous cell carcinoma.
    Wang X; Ren X; Liu W; Chen X; Wei J; Gong Z; Yan Y; Xu Z
    Mol Med Rep; 2020 Mar; 21(3):1517-1526. PubMed ID: 32016472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse expression of RNA-binding protein IMP3 predicts high-stage lymph node metastasis and poor prognosis in colorectal adenocarcinoma.
    Yuan RH; Wang CC; Chou CC; Chang KJ; Lee PH; Jeng YM
    Ann Surg Oncol; 2009 Jun; 16(6):1711-9. PubMed ID: 19357927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
    Chromecki TF; Cha EK; Pummer K; Scherr DS; Tewari AK; Sun M; Fajkovic H; Roehrborn CG; Ashfaq R; Karakiewicz PI; Shariat SF
    BJU Int; 2012 Jul; 110(1):63-8. PubMed ID: 22077633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Insulin-like growth factor 2 mRNA-binding protein-3 as a marker for distinguishing between cutaneous squamous cell carcinoma and keratoacanthoma.
    Kanzaki A; Kudo M; Ansai S; Peng WX; Ishino K; Yamamoto T; Wada R; Fujii T; Teduka K; Kawahara K; Kawamoto Y; Kitamura T; Kawana S; Saeki H; Naito Z
    Int J Oncol; 2016 Mar; 48(3):1007-15. PubMed ID: 26782292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of SOX4 is a biomarker for malignant status and poor prognosis in patients with non-small cell lung cancer.
    Wang D; Hao T; Pan Y; Qian X; Zhou D
    Mol Cell Biochem; 2015 Apr; 402(1-2):75-82. PubMed ID: 25567207
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype.
    Walter O; Prasad M; Lu S; Quinlan RM; Edmiston KL; Khan A
    Hum Pathol; 2009 Nov; 40(11):1528-33. PubMed ID: 19695680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.